| NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock is formulated with purified, intact viral particles, that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0mL of NATtrol SARS-CoV-2 Variant B.1.351 stock in a proprietary matrix at the target concentration. NATtrol SARS-CoV-2 Variant B.1.351 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.351 RNA. NATtrol SARS-CoV-2 Variant B.1.351 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error. Material Safety Data Sheet.pdf |
Technical Features and Specifications
| Product Code | NATSARS(COV2-SA)-ST |
|---|---|
| Origin | USA |
| BTN - HS | 38221900 |
| Size | 1.0 ml |
| KGS | 0.001 |
| Shipping Conditions | +2° to +8° C. |
| Platform | Real-Time PCR,Applied Biosystems QuantStudio |
| Classification/Permits | Non hazardous biological reagents/RUO |